Hopital De La Croix-Rousse — Clinical Trial Site

69 Registered trials

24 Currently recruiting

Organisation

Hopital De La Croix-Rousse

Location

Lyon Cedex 04, France

Identifier

ORG-100028712

Address

103 Grande Rue De La Croix Rousse, 69317, France

Departments

1802: Gastroenterology
250003: Ophtalmologie
anesthésie-réanimation
Cardiology
chirugie Digestive et Générale
Dermatology
Gastro enterology
Gastroenterology
Gynecology - Obstetrics
hépato gastro enterology
Hépato Gastroentérologie
Hepato-gastro-enterology department
Hépato-gastroentérologie
Hépato-gastroentérologue oncologue
Hepato-gastroenterology
Hepato-Gastroenterology Department
Hepatogastro enterology
Hepatology
Hepatology and Gastroenterology
Hepatology and gastroenterology department
Hopital de la croix rousse; Ophtalmologie
Hospital de Lyon Nord – Croix Rousse
Infectiologie
Infectious and tropical diseases
Infectious diseas
Infectious disease
Infectious Diseases
Internal Medecine
Médecine Intensive et Réanimation
Médecine Interne
Medical oncology
Oncologie
Oncologie médicale
Oncology
Ophtalmologie
Ophtalmology
Ophthalmology
ORL et Chirurgie Cervico-faciale
Pneumologie
Pneumology
Service d'Hépato Gastro Entérologie
Service d'Hépato-Gastro-Entérologie
Service d'hépatologie et gastroentérologie
Service d'oncologie médicale
Service d'ophtalmologie
Service d'Ophtalomologie
Service d’ophtalmologie
Service de Pneumologie
Service Hépato-Gastroenterologie
Service pneumologie
site 008_Service Maladies infectieuses et tropicales

Clinical trials at this site (69)

Search interface

PRODIGE 34 - ADAGE: Randomised phase III study evaluating adjuvant chemotherapy after resection of stage III colon adenocarcinoma in patient… Ended

2024-518741-21-00 colon cancer 4 2014-12-23
Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dos… Ended

2023-506000-50-00 Adult Patients with Moderate-to-Severe Asthma Uncontrol 4 2024-09-26
A Study to Evaluate the Efficacy and Safety of Faricimab in Patients with Choroidal Neovascularization Secondary to Pathologic Myopia Ended

2023-506707-25-00 Choroidal neovascularization secondary to pathologic my 5 2024-04-09
"Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease (COPD) with a History of Exacerbations (MIRANDA)" Ended

2023-505543-39-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2024-02-12
A study to learn how well a higher amount of aflibercept given as an injection into the eye works and how safe it is in people with reduced … Ended

2022-502174-16-00 Macular edema secondary to retinal vein occlusion 5 2023-09-13
A Phase 2b Study of MK-6024 in Adults with Precirrhotic Nonalcoholic Steatohepatitis Ended

2022-502647-35-00 Non-alcoholic steatohepatitis 4 2023-09-01
Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory Non-infectious Non-anterior Uveitis (JAKUVEITE) Ended

2024-513802-77-00 Active non-anterior non-infectious uveitis 5 2023-08-30
A STUDY TO INVESTIGATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF RO7200220 ADMINISTERED INTRAVITREALLY IN PATIENTS WIT… Ended

2022-501794-39-00 Uveitic Macular Edema 5 2023-06-28
Long-term Efficacy and Safety of Tozorakimab in Participants with Chronic Obstructive Pulmonary Disease with a History of Exacerbations. Ended

2022-501063-41-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2023-04-20
A clinical study to evaluate a new medicinal product VS-01 in patients with an acute episode on top of a chronic liver disease (called acute… Ended

2024-513706-56-00 Acute-on-chronic liver failure (ACLF) is characterized 4 2023-03-22
Phase 2b Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis Ended

2024-514975-16-00 Non-infectious, Intermediate-, Posterior- or Pan-uveiti 4 2022-12-22
Study to assess efficacy, safety, and tolerability of Tozorakimab in patients with symptomatic chronic obstructive pulmonary disease (COPD) … Ended

2023-503572-24-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2022-03-02
Study comparing the standard administration of immunotherapy (IO) versus the same agent administered each three months in patients with loca… Ended

2024-513707-14-00 Only patients with oncologic locally advanced or metast 5 2022-01-14
An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects with Geographic Atrophy Secondary to … Ended

2024-512945-18-00 Geographic Atrophy Secondary to Age-Related Macular Deg 5 2021-11-30
A Phase 3, Randomized, Double-Blind Study of Ociperlimab, an Anti-TIGIT Antibody, in Combination With Tislelizumab Compared to Pembrolizumab… Ended

2023-507317-10-00 Locally advanced, unresectable, or metastatic non small 5 2021-05-10
Study Evaluating the Efficacy and Safety of Belapectin (GR-MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis Ended

2024-512619-28-00 Esophageal Varices in NASH Cirrhosis 10 2021-03-08
Randomized trial evaluating adapted chemotherapy in patients with squamous carcinoma Ended

2024-512456-38-00 locally advanced squamous cell carcinoma 4 2021-02-04
A Study of Relatlimab in Combination with Nivolumab in Participants with Advanced Liver Cancer who have never been been Treated with Immuno-… Ended

2023-503519-13-00 Advanced Hepatocellular Carcinoma 4 2020-12-14
A multicentre phase II, open-label, non-randomized study evaluating Platinum-Pemetrexed-Atezolizumab ( Bevacizumab) for patients with stage … Ended

2024-516201-23-00 Lung Cancer, NSCLC 4 2019-08-26
CONDYVAC. Efficacy study of the quadrivalent Human Papilloma Virus (HPV) vaccine to prevent recurrence of External Genital Warts (EGW) in pa… Ended

2024-516098-62-00 External Genital Warts (EGW) 5 2018-01-11
A Phase III Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant MEDI4736 in Completely Resected Non-Small Cell Lung Can… Ended

2024-517856-36-00 Completely resected primary stage IB (≥ 4cm), II and II 5 2015-03-09